Showing results (541-550 of 743) with videos related to
Sort By:
Pageof 75
Nature Communications|April 25, 2018
Evolution of high-level resistance during low-level antibiotic exposureErik Wistrand-Yuen, Michael Knopp, Karin Hjort, et al.Cellular Microbiology|February 24, 2001
Salmonella typhimurium mutants that downregulate phagocyte nitric oxide productionS Eriksson, J Björkman, S Borg, et al.Proceedings of the National Academy of Sciences of the United States of America|April 26, 2006
Reducing the fitness cost of antibiotic resistance by amplification of initiator tRNA genesAnnika I Nilsson, Anna Zorzet, Anna Kanth, et al.Frontiers in Cellular and Infection Microbiology|May 27, 2022
A Microfluidic Chip for Studies of the Dynamics of Antibiotic Resistance Selection in Bacterial BiofilmsPo-Cheng Tang, Olle Eriksson, Josefin Sjögren, et al.Journal of the National Cancer Institute. Monographs|January 1, 1997
Updated overview of the Swedish Randomized Trials on Breast Cancer Screening with Mammography: age group 40-49 at randomizationL G Larsson, I Andersson, N Bjurstam, et al.Ebiomedicine|February 22, 2025
Machine learning detection of heteroresistance in Escherichia coliAndrei Guliaev, Karin Hjort, Michele Rossi, et al.Scientific Reports|October 15, 2025
Fast detection of synergy and antagonism in antifungal combinations used against Candida albicans clinical isolatesHanna Lundvik, Ramona Santini, Tugce Unalan Altintop, et al.Proceedings of the National Academy of Sciences of the United States of America|November 22, 2001
Mutation frequency and biological cost of antibiotic resistance in Helicobacter pyloriB Björkholm, M Sjölund, P G Falk, et al.The Journal of Antimicrobial Chemotherapy|September 16, 2003
Bacteria with increased mutation frequency and antibiotic resistance are enriched in the commensal flora of patients with high antibiotic usageIngegerd Gustafsson, Maria Sjölund, Erik Torell, et al.British Journal of Pharmacology|April 27, 2005
Direct gas measurements indicate that the novel cyclooxygenase inhibitor AZD3582 is an effective nitric oxide donor in vivoL Christofer Adding, Per Agvald, Lars I Andersson, et al.Pageof 75